Merck had the best two day gain ever in its history. After a 38% gain, this afternoon smart money was selling in the wake of massive short covering as measured by our proprietary studies. The initial trigger to the upside today was an analyst upgrade.

Nothing fundamental has changed in our view that Obama Health Plan will pressure big pharma.

Schering-Plough SGP acquisition does not solve MRK’s problems. MRK has paid a full price and there is still a possibility of a bidding war with Johnson & Johnson (JNJ) over SGP.

Consider start scaling in a short position right here at $27.15